On Nov 28 & 29, the American Conference Institute (ACI) will be hosting the conference "Definitive Legal, Regulatory, and Commercial Guide to Orphan Drugs and Rare Diseases" in Boston, MA.
Rare Disease Report is proud to be a media partner with ACI for this important event. The conference will provide attendees with valuable insight into the regulatory, legal, and commercial implications of getting orphan drugs to market.
The conference will have over two dozen speakers offering a variety of perspectives from regulatory (Tim Cote), advocacy (Pat Furlong), business (Kelly Longo), legal (Geoffrey Levitt), and drug development (Christopher-Paul Milne) backgrounds.
For more information about this conference, please visit [ Ссылка ].
Rare Disease Report will be providing coverage of this meeting starting November 28th.
